Intra-Cellular Therapies (I2TC34.SA) Q1 2025 Earnings

Feb 21Confirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.61
-1.21
-0.82
-0.42

Details

Expected EPS
-0.42208891559999995
Actual EPS
-0.9171360000000001
Surprise EPS
-0.5
Surprise Percent
-117.29%

Description

⁨Intra-Cellular Therapies⁩ (⁦I2TC34.SA⁩) has reported earnings of ⁦-0.9171360000000001⁩ per share for ⁦Q1 2025⁩.

0 Comments

Share your thoughts